Current concepts in the management of diabetic polyneuropathy

Diagnosing peripheral neuropathy in South‐East Asia: A focus on diabetic neuropathy

(2020) Rayaz A Malik et al.   Journal of Diabetes Investigation

Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study

(2020) Mamdouh R. El-Nahas et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Capsaicin 8% dermal patch in clinical practice: an expert opinion

(2020) Cesare Bonezzi et al.   EXPERT OPINION ON PHARMACOTHERAPY

Novel Insights into Sensorimotor and Cardiovascular Autonomic Neuropathy from Recent-Onset Diabetes and Population-Based Cohorts

(2019) Christian Herder et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis

(2019) E. Morgan Pollard et al.   Journal of Pain Research

A cross-sectional study to evaluate diabetes management, control and complications in 1631 patients with type 2 diabetes mellitus in Vietnam (DiabCare Asia)

(2019) Khue Thy Nguyen et al.   International Journal of Diabetes in Developing Countries

Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study)

(2018) Dan Ziegler et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Efficacy of epalrestat plus α-lipoic acid combination therapy versus monotherapy in patients with diabetic peripheral neuropathy: a meta-analysis of 20 randomized controlled trials

(2018) Lin Luo et al.   Neural Regeneration Research

Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy

(2018) et al.   JAMA Neurology

Lack of a Clinically Significant Pharmacokinetic Interaction Between Pregabalin and Thioctic Acid in Healthy Volunteers

(2018) Su-jin Rhee et al.   CLINICAL THERAPEUTICS

Emerging biomarkers, tools, and treatments for diabetic polyneuropathy

(2018) Gidon J Bönhof et al.   ENDOCRINE REVIEWS

A Case for Alpha-Lipoic Acid as an Alternative Treatment for Diabetic Polyneuropathy

(2018) Ngoc Nguyen et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial

(2018) Kongkiat Kulkantrakorn et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life

(2017) Julie M. Waldfogel et al.   NEUROLOGY

Diabetic Neuropathy: A Position Statement by the American Diabetes Association

(2016) Rodica Pop-Busui et al.   DIABETES CARE

Association of transketolase polymorphisms with measures of polyneuropathy in patients with recently diagnosed diabetes

(2016) Dan Ziegler et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Systematic review of treatments for diabetic peripheral neuropathy

(2016) N. Çakici et al.   DIABETIC MEDICINE

A Qualitative Systematic Review of Head-to-Head Randomized Controlled Trials of Oral Analgesics in Neuropathic Pain

(2016) C Peter N Watson et al.   Pain Research & Management

From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy

(2015) Dan Ziegler et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy

(2015) Michael Polydefkis et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

(2015) Nanna B Finnerup et al.   LANCET NEUROLOGY

Diabetic Neuropathy

(2014) D. Ziegler et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Efficacy of α-lipoic acid in diabetic neuropathy

(2014) Nikolaos Papanas et al.   EXPERT OPINION ON PHARMACOTHERAPY

Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus

(2014) Jack R W Brownrigg et al.   HEART

Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride

(2014) Feifan Xie et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Efficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-Analysis

(2014) Xin Hu et al.   PLoS One

Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

(2013) Catherine L. Martin et al.   DIABETES CARE

Whither pathogenetic treatments for diabetic polyneuropathy?

(2013) Andrew J. M. Boulton et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

(2013) Solomon Tesfaye et al.   PAIN

Diabetes management in Thailand: a literature review of the burden, costs, and outcomes

(2013) Chaicharn Deerochanawong et al.   Globalization and Health

Older Subjects With Diabetes and Prediabetes Are Frequently Unaware of Having Distal Sensorimotor Polyneuropathy: The KORA F4 Study

(2012) B. W. C. Bongaerts et al.   DIABETES CARE

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neurop

(2012) N. Hotta et al.   DIABETIC MEDICINE

Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials

(2012) Gerritje S. Mijnhout et al.   International Journal of Endocrinology

0.025% Capsaicin Gel for the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Crossover, Placebo-Controlled Trial

(2012) Kongkiat Kulkantrakorn et al.   Pain Practice

Efficacy and Safety of Antioxidant Treatment With  -Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial

(2011) D. Ziegler et al.   DIABETES CARE

Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

(2010) J. Calles-Escandon et al.   DIABETES CARE

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

(2010) S. Tesfaye et al.   DIABETES CARE

The multifaceted therapeutic potential of benfotiamine

(2010) Pitchai Balakumar et al.   PHARMACOLOGICAL RESEARCH

Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients

(2009) D. Ziegler et al.   DIABETES CARE

A Benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy

(2009) H. Stracke et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes

(2009) Lawrence H. Young et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes

(2008) X. Du et al.   DIABETOLOGIA

Benfotiamine in Diabetic Polyneuropathy (BENDIP): Results of a Randomised, Double Blind, Placebo-controlled Clinical Study

(2008) H. Stracke et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE